AIP
CYT

Ameritas Investment Partners’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History

Ameritas Investment Partners’s Portfolio CYT Stock Details CYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-641
Closed -$2K – 3297
2022
Q1 		$2K Hold
641
– – ﹤0.01% 3055
2021
Q4 		$7K Hold
641
– – ﹤0.01% 2999
2021
Q3 		$11K Buy
+641
New +$12K ﹤0.01% 2926

Other funds holding CYT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameritas Investment Partners's CYT Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Cyteir Therapeutics, Inc. Common Stock (CYT) in Q2 2022, closing a stake of 641 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in CYT in Q3 2021 and held it in 3 quarters. The position peaked at $11K in Q3 2021. 45 funds tracked by Wall St. Rank hold CYT as of Q2 2022.

  • Ameritas Investment Partners reported no remaining Cyteir Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 641 Cyteir Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Ameritas Investment Partners first reported a position in Cyteir Therapeutics, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Ameritas Investment Partners's Cyteir Therapeutics, Inc. Common Stock position peaked at $11K in Q3 2021.
  • 45 funds tracked by Wall St. Rank held Cyteir Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.